Viewing Study NCT02505568


Ignite Creation Date: 2025-12-24 @ 5:34 PM
Ignite Modification Date: 2026-01-21 @ 3:36 PM
Study NCT ID: NCT02505568
Status: COMPLETED
Last Update Posted: 2019-10-17
First Post: 2015-06-29
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate Efficacy and Safety of Infliximab in Participant With Moderate-to-Severe Refractory Intestinal Behcet's Disease
Sponsor: Janssen Korea, Ltd., Korea
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module